These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 7725807

  • 1. [NSAID-induced ulcers--therapy and prevention].
    Rösch W.
    Z Rheumatol; 1995; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
    [Abstract] [Full Text] [Related]

  • 2. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 3. [Current state of treatment and prevention of gastroduodenal side effects of non-steroidal antirheumatic drugs].
    Bolten W.
    Leber Magen Darm; 1991 Sep; 21(5):193-4, 196. PubMed ID: 1758234
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 5. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 6. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 15; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 7. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A.
    Rev Gastroenterol Mex; 2004 Mar 15; 69(4):251-60. PubMed ID: 15765979
    [Abstract] [Full Text] [Related]

  • 8. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.
    Gastroenterology; 2007 Sep 15; 133(3):790-8. PubMed ID: 17854591
    [Abstract] [Full Text] [Related]

  • 9. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 10. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990 Oct 15; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

  • 11. Management of NSAID-induced ulcer disease.
    Clearfield HR.
    Am Fam Physician; 1992 Jan 15; 45(1):255-8. PubMed ID: 1728095
    [Abstract] [Full Text] [Related]

  • 12. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 13. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM, Bytzer P.
    Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151
    [Abstract] [Full Text] [Related]

  • 14. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct 29; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 15. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M, Bertschinger P.
    Schweiz Med Wochenschr; 1996 Sep 14; 126(37):1569-72. PubMed ID: 8927961
    [Abstract] [Full Text] [Related]

  • 16. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A, Wells G, Tugwell P, Welch V, Dubé C, McGowan J.
    J Rheumatol; 2000 Sep 14; 27(9):2203-14. PubMed ID: 10990235
    [Abstract] [Full Text] [Related]

  • 17. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 14; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct 14; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 19. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA.
    Arthritis Res Ther; 2007 Oct 14; 9(3):R52. PubMed ID: 17521422
    [Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Oct 14; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.